This pillar transforms medicinal plants, natural products, bioactive molecules and scientific discoveries into innovative health products and therapeutic technologies.
Sholab’s work encompasses botanical medicines, nutraceuticals, functional foods, bioactive extracts, drug-discovery leads and technology platforms addressing areas such as infectious diseases, sickle cell disease, metabolic disorders and wellness.
Flagship research includes the C230 platform, Verbascoside/Isoverbascoside technologies, Melaleuca bracteata, mangiferin and other African medicinal-plant innovations.



